NGNE
Neurogene, Inc. Common Stock
$16.89
-0.79%
-0.14
Notify me if price changes either direction
Buy NGNE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
261.6M
Enterprise value
8.1M
Trailing PE
-3.9252334666029
Forward PE
-3.7117906
PEG Ratio
0.23355139126287
Enterprise to EBITDA
-0.086
Enterprise to revenue
8.7833513513514
Price to book MRQ
0.9459159
Price to sales TTM
282.83537513514
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
925.0K
EBITDA
-94208000
Diluted EPS TTM
-4.1
Total Cash (MRQ)
265.4M
Current ratio (MRQ)
18.39
Operating Cash Flow (TTM)
-77240000
NGNE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
